@extends('layouts.app')
@section('content')
    <div style="height:0px;width:0px;overflow:hidden;-webkit-margin-top-collapse: separate;"></div>
    <div id="ttr_page" class="container">
        <div id="ttr_content_and_sidebar_container">
            <div id="ttr_content">
                <div id="ttr_html_content_margin" class="container-fluid">
                    <div style="height:0px;width:0px;overflow:hidden;-webkit-margin-top-collapse: separate;"></div>
                    <div class="ttr_neuroscience_html_row0 row">
                        <div class="post_column col-lg-12 col-md-12 col-sm-12 col-xs-12">
                            <div class="ttr_neuroscience_html_column00">
                                <div style="height:0px;width:0px;overflow:hidden;-webkit-margin-top-collapse: separate;"></div>
                                <div class="html_content"><h1 style="margin:7.14em 0em 0.36em 0em;text-align:Center;line-height:1.49142857142857;"><span style="font-family:'Crimson Text','Geneva','Arial';font-weight:600;font-size:3.429em;color:rgba(255,255,255,1);">Neuroscience</span><br style="font-family:'Crimson Text','Geneva','Arial';font-style:italic;font-weight:600;font-size:2em;color:rgba(255,255,255,1);" /><span style="font-family:'Crimson Text','Geneva','Arial';font-style:italic;font-weight:600;font-size:2em;color:rgba(255,255,255,1);">Treating chronic disabling neurological conditions</span></h1><h1 style="margin:7.14em 0em 0.36em 0em;text-align:Center;line-height:1.49142857142857;"><br style="font-family:'Crimson Text','Geneva','Arial';font-style:italic;font-weight:600;font-size:2em;color:rgba(255,255,255,1);" /></h1></div>
                                <div style="height:0px;width:0px;overflow:hidden;-webkit-margin-top-collapse: separate;"></div>
                                <div style="clear:both;"></div>
                            </div>
                        </div>
                        <div class=" visible-lg-block visible-sm-block visible-md-block visible-xs-block" style="clear: both;"></div>
                    </div>
                    <div class="ttr_neuroscience_html_row1 row">
                        <div class="post_column col-lg-6 col-md-6 col-sm-6 col-xs-12">
                            <div class="ttr_neuroscience_html_column10">
                                <div style="height:0px;width:0px;overflow:hidden;-webkit-margin-top-collapse: separate;"></div>
                                <div class="html_content"><br style="line-height:1.57142857142857;" /><p style="margin:0.36em 0em 0.36em 0em;text-align:Justify;line-height:1.57142857142857;"><span style="font-size:1.143em;">At Remedium Bio-Technology we are constantly discovering compoun that have the potential to treat chronic disabling neurological conditions. </span></p><p style="margin:0.36em 0em 0.36em 0em;text-align:Justify;line-height:1.57142857142857;"><span style="font-size:1.143em;">These conditions and ailments include MS, Parkinson's disease and Alzheimer's. We are also advancing research across several neurodegenerative disorders, including multiple sclerosis. </span></p><p style="margin:0.36em 0em 0.36em 0em;text-align:Justify;line-height:1.57142857142857;"><span style="font-size:1.143em;">We will undergo research to gain a deeper understanding of the biological mechanisms underlying neurodegenerative diseases. Our goal is to identify novel therapeutic approaches for bringing relief to patients living with these chronic, debilitating diseases. </span></p><p style="margin:0.36em 0em 0.36em 0em;text-align:Justify;line-height:1.57142857142857;"><span style="font-size:1.143em;">As the number of patients and caregivers seeking help from the health care system increases, Alzheimer's represents a growing challenge for society. Current treatments simply address the symptoms and do nothing to prevent the progression of the disease or reverse the damage. </span></p><p style="margin:0.36em 0em 0.36em 0em;text-align:Justify;line-height:1.57142857142857;"><span style="font-size:1.143em;">Remedium Bio-Technology is collaborating with some of the world's leading Alzheimer's researchers to identibr ways of stopping the disease in its earliest stages. Our anti-tau antibody is currently being investigated to treat Alzheimer's disease and progressive supra-nuclear palsy, (PSP), and currently advancing to phase 2 development.</span></p></div>
                                <div style="height:0px;width:0px;overflow:hidden;-webkit-margin-top-collapse: separate;"></div>
                                <div style="clear:both;"></div>
                            </div>
                        </div>
                        <div class=" visible-xs-block" style="clear: both;"></div>
                        <div class="post_column col-lg-6 col-md-6 col-sm-6 col-xs-12">
                            <div class="ttr_neuroscience_html_column11">
                                <div style="height:0px;width:0px;overflow:hidden;-webkit-margin-top-collapse: separate;"></div>
                                <div class="html_content"><br style="line-height:1.57142857142857;" /><p style="margin:0.36em 0em 0.36em 0em;text-align:Justify;line-height:1.57142857142857;"><span style="font-size:1.143em;">Multiple sclerosis, or MS, is a progressive chronic disorder of the nervous system that is most often seen in patients between the ages of 20 and 40. In MS, the immune system attacks a protein called myelin, which forms a protective sheet around neuro-fibers. When myelin is damaged by MS, neurons struggle to communicate, leading to an accumulation of neuronal loss, atrophy and significant disability over time. </span></p><p style="margin:0.36em 0em 0.36em 0em;text-align:Justify;line-height:1.57142857142857;"><span style="font-size:1.143em;">We are committed to meeting the needs of patients with MS, and we are currently supporting treatment options that promote nerve protection and facilitate neuronal regeneration. </span></p><p style="margin:0.36em 0em 0.36em 0em;text-align:Justify;line-height:1.57142857142857;"><span style="font-size:1.143em;">Parkinson's disease is the second most-common neurodegenerative disorder, affecting more than 10 million people worldwide. In addition to our available treatments for advanced Parkinson's, we are currently exploring other pathways that could provide patients with a new method of treatment for this progressive chronic disease. </span></p><p style="margin:0.36em 0em 0.36em 0em;text-align:Justify;line-height:1.57142857142857;"><span style="font-size:1.143em;">We are also developing a new delivery system to enhance the patient and caregiver experience while administering our existing therapy for Parkinson's disease.</span></p><br style="margin:0.36em 0em 0.36em 0em;text-align:Justify;line-height:1.57142857142857;" /><br style="margin:0.14em 0em 0em 0.57em;line-height:1.57142857142857;" /></div>
                                <div style="height:0px;width:0px;overflow:hidden;-webkit-margin-top-collapse: separate;"></div>
                                <div style="clear:both;"></div>
                            </div>
                        </div>
                        <div class=" visible-lg-block visible-sm-block visible-md-block visible-xs-block" style="clear: both;"></div>
                    </div>
                    <div class="ttr_neuroscience_html_row2 row">
                        <div class="post_column col-lg-12 col-md-12 col-sm-12 col-xs-12">
                            <div class="ttr_neuroscience_html_column20">
                                <div style="height:0px;width:0px;overflow:hidden;-webkit-margin-top-collapse: separate;"></div>
                                <div class="html_content"><p style="text-align:Center;"><span style="font-weight:700;color:rgba(32,32,32,1);">Accredited by:</span></p></div>
                                <div style="height:0px;width:0px;overflow:hidden;-webkit-margin-top-collapse: separate;"></div>
                                <div style="clear:both;"></div>
                            </div>
                        </div>
                        <div class=" visible-lg-block visible-sm-block visible-md-block visible-xs-block" style="clear: both;"></div>
                    </div>
                    <div style="height:0px;width:0px;overflow:hidden;-webkit-margin-top-collapse: separate;"></div>
                </div><!--content_margin-->
            </div><!--content-->
            <div style="clear:both">
            </div>
        </div><!--container-->
    </div><!--page-->
    <div style="height:0px;width:0px;overflow:hidden;"></div>
@endsection
